Kaken Pharmaceutical Launches Bigger Arthritis Patch
This article was originally published in PharmAsia News
Kaken Pharmaceutical announced that it will launch on Sept. 24 a bigger version of Adfeed (flurbiprofen poultice) 80mg, an antiphlogistic analgetic patch. The prescription product is twice the size of the current version. The size increase allows patients flexibility to choose different sizes depending on the affected area. The patch is to be used on the affected area twice daily. (Click here for more - Japanese language) "Kaken Phamarecitical Launches Bigger Sized Antiphlogistic Analgetic Patch" - Nikkei Sangyo News (9/23/08)
You may also be interested in...
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.
In the age of coronavirus, human factors professionals are doing their best to find their way through the pandemic by putting unique twists on usability testing to see what works and what doesn’t in the new reality. That’s the topic of this week’s podcast.